Immuron Limited's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 24.89, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Immuron Limited in Jun 30 2025 quarter, has decreased to 15 days, compared to 20 days, in the 0 quarter.

If we take a look into Healthcare sector 473 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 0 to 3266.

What is Receivable Turnover Ratio?
What is Immuron Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IMRN Receivables Turnover Ratio	(Jun 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) IV. Quarter
Y / Y Receivable Change	34 %	34 %	-	-	-
Y / Y Revenue Change	55.99 %	-	-	-	192.95 %
Receivable Turnover Ratio (TTM)	24.89	18.28	21.39	21.39	21.39
IMRN's Total Ranking	# 3266	# 0	#	#	#
Accounts Receivable average collection period days	15	20	17	17	17
Seq. Receivable Change	0 %	-	-	-	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 159
Healthcare Sector	# 474
Overall Market	# 3266

Receivable Turnover Ratio Statistics
High	Average	Low
4.39	2.87	0.5
(Jun 30 2019)		(Jun 30 2021)

IMRN Company Profile • Back to IMRN Efficiency Comparisons • Compare IMRN Receivables Turnover Ratio to its Competitors

Financial Statements
Immuron Limited's Accounts Receivable	$ 1 Millions	Visit IMRN's Balance sheet
Immuron Limited's Sales TTM	$ 7 Millions	Visit IMRN's Income Statement
Sources of IMRN's Revenues		Visit IMRN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IMRN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IMRN's Growth Rates	IMRN's Roa	IMRN's Inventory Turnover Ratio	IMRN's Dividend Comparisons
IMRN's Profitability Ratios	IMRN's Roi	IMRN's Asset Turnover Ratio	IMRN's Dividend Growth
IMRN's Valuation Ratios	IMRN's Roe	IMRN's Financial Strength Ratios	IMRN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
Lucid Diagnostics Inc	33.67	$ 4.360 Millions	$ 0.130 Millions
Neuroone Medical Technologies Corp	31.71	$ 7.183 Millions	$ 0.226 Millions
Invo Fertility Inc	31.23	$ 6.620 Millions	$ 0.212 Millions
Orchestra Biomed Holdings Inc	31.07	$ 2.944 Millions	$ 0.095 Millions
Polomar Health Services, Inc.	30.13	$ 0.041 Millions	$ 0.001 Millions
U S Physical Therapy Inc	29.11	$ 729.612 Millions	$ 25.062 Millions
Lineage Cell Therapeutics Inc	28.87	$ 10.914 Millions	$ 0.378 Millions
Lifemd Inc	28.74	$ 244.476 Millions	$ 8.507 Millions
Vireo Growth Inc.	28.69	$ 122.752 Millions	$ 4.278 Millions
Keros Therapeutics Inc	27.81	$ 251.948 Millions	$ 9.059 Millions
Sangamo Therapeutics Inc	27.79	$ 81.706 Millions	$ 2.940 Millions
Cv Sciences Inc	27.01	$ 12.957 Millions	$ 0.480 Millions
Vaxart Inc	26.61	$ 80.724 Millions	$ 3.033 Millions
Igc Pharma Inc	26.02	$ 1.327 Millions	$ 0.051 Millions
Electrocore Inc	25.68	$ 26.902 Millions	$ 1.048 Millions
Fonar Corporation	24.32	$ 104.351 Millions	$ 4.291 Millions
Aquestive Therapeutics Inc	24.04	$ 44.132 Millions	$ 1.836 Millions
Nutriband Inc	23.52	$ 2.578 Millions	$ 0.110 Millions
Innovative Eyewear Inc	23.52	$ 1.978 Millions	$ 0.084 Millions
Bioxcel Therapeutics Inc	22.99	$ 0.868 Millions	$ 0.038 Millions
Meiragtx Holdings Plc	21.55	$ 37.917 Millions	$ 1.760 Millions
Bespoke Extracts Inc	20.45	$ 1.233 Millions	$ 0.060 Millions
Precipio inc	19.83	$ 21.242 Millions	$ 1.071 Millions
Sonida Senior Living Inc	19.77	$ 352.129 Millions	$ 17.815 Millions
Innovage Holding Corp	19.44	$ 853.699 Millions	$ 43.903 Millions
Neuraxis Inc	19.23	$ 3.218 Millions	$ 0.167 Millions
Nurix Therapeutics Inc	18.61	$ 88.381 Millions	$ 4.750 Millions
Clene Inc	17.88	$ 0.286 Millions	$ 0.016 Millions
Valion Bio Inc	17.77	$ 0.462 Millions	$ 0.026 Millions
Xoma Royalty Corporation	17.55	$ 44.952 Millions	$ 2.561 Millions

Date modified: 2026-07-07T11:25:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.